Healx secures $47m to advance AI-driven rare disease treatments
Genetic Engineering & Biotechnology News (GEN) - 01-Aug-2024The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502
Join the club for FREE to access the whole archive and other member benefits.
Venture capital firm
Balderton Capital is a London-based venture capital firm that invests in early-stage technology startups across Europe. With a focus on building global companies, Balderton provides funding, strategic support, and expertise to help ambitious founders scale their businesses.
Visit website: https://www.balderton.com/
Details last updated 12-Feb-2025
The UK-based company prepares for clinical trials with its innovative NF1 drug, HLX-1502